par Jones, Robin Lewis;Ratain, Mark M.J.;O'Dwyer, Peter P.J.;Siu, Lillian L;Jassem, Jacek;Medioni, Jacques;DeJonge, Maja;Rudin, Charles;Sawyer, Michael M.B.;Khayat, David;Awada, Ahmad
;de Vos-Geelen, Judith J.M.P.G.M.;Evans, Thomas Ronald Jeffrey;Obel, Jennifer;Brockstein, Bruce;DeGreve, Jacques;Baurain, Jean-Francois;Maki, Robert;D'Adamo, David;Dickson, Mark;Undevia, Samir;Geary, David;Janisch, Linda;Bedard, Philippe L;Abdul Razak, Albiruni Ryan;Kristeleit, Rebecca;Vitfell-Rasmussen, Joanna;Walters, Ian;Kaye, Stan S.B.;Schwartz, Gary
Référence European journal of cancer, 120, page (132-139)
Publication Publié, 2019-10

Référence European journal of cancer, 120, page (132-139)
Publication Publié, 2019-10
Article révisé par les pairs
Titre: |
|
Auteur: | Jones, Robin Lewis; Ratain, Mark M.J.; O'Dwyer, Peter P.J.; Siu, Lillian L; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael M.B.; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith J.M.P.G.M.; Evans, Thomas Ronald Jeffrey; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jean-Francois; Maki, Robert; D'Adamo, David; Dickson, Mark; Undevia, Samir; Geary, David; Janisch, Linda; Bedard, Philippe L; Abdul Razak, Albiruni Ryan; Kristeleit, Rebecca; Vitfell-Rasmussen, Joanna; Walters, Ian; Kaye, Stan S.B.; Schwartz, Gary |
Informations sur la publication: | European journal of cancer, 120, page (132-139) |
Statut de publication: | Publié, 2019-10 |
Sujet CREF: | Cancérologie |
Mots-clés: | Brivanib |
FGF2 status | |
Ovarian cancer | |
Randomised discontinuation trial | |
Sarcomas | |
Solid tumours | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2019.07.024 | |
info:pii/S0959804919304435 | |
info:scp/85072047537 | |
info:pmid/31522033 |